x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

34:03

Top 5 episodes of all time

Molecule to Market: Inside the outsourcing space ·

2022/11/18

As we celebrate the podcast hitting 30,000 downloads and approaching its 100th episode, Raman reflects on the most downloaded episodes with highlights from the top 5. In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector, diving into the top 5 episodes of all time, featuring: JoyL Silva, Pfizer CentreOne discussing: her early career journey and advice, industry trends, and personalized medicines Tia Lyles-Williams, LucasPye Bio

en

23:59

CPHI 2022 - Trends, challenges & opportunities

Molecule to Market: Inside the outsourcing space ·

2022/11/11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses emerging trends and challenges for the life sciences sector live from CPHI Frankfurt 2022, with: Grainne Hughes, Vice President of Business Support Operations at Almac Christine Fürst, Senior Director Key Account Manager Europe at Vetter Pharma Guido Wallraff, Corporate Business Development Director at Ardena Jenny Gattari, CDMO Business

en

15:13

Views from AAPS 2022

Molecule to Market: Inside the outsourcing space ·

2022/10/28

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses future industry trends live from AAPS Boston 2022, with: Casey Franklin, VP of Business Development at Alcami Umberto Romeo, R&D Manager at Corden Pharma Steven Dodd, Executive Director for sales strategy at Icon CRO Paul Dickinson, Founder & CSO at Seda Pharmaceutical Development Services Raman finds out more about the

en

50:10

The Personalized Medicine Pioneer

Molecule to Market: Inside the outsourcing space ·

2022/10/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Katz, Founder & CSO at Sparrow Pharmaceuticals, Inc.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering: The contrast of developing new drugs and running clinical trials in a big pharma versus his journey as the founder of a virtual biopharma company. What life really looks like and skills you have to develop in a firm

en

45:34

Inizio’s biotech bromance

Molecule to Market: Inside the outsourcing space ·

2022/10/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason McKenna, Global President, and Dean McAlister, Executive Vice President both from Inizio Biotech. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with the dynamic duo, covering: A wealth of big pharma learnings for today’s emerging biotechs. The (good and bad) impact of the current biotech capital market slowdown on decision-making for

en

53:03

The Magic of Drug Development

Molecule to Market: Inside the outsourcing space ·

2022/09/29

In this special episode of Molecule to Market, we go back inside the global drug development space with Marcelo Bigal, President and CEO, of Ventus Therapeutics, and Versant Venture Partner, who shares his journey from being a neurologist to taking a drug to market when he became part of Teva Pharmaceuticals and now is a CEO. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Marcelo, covering: What it feels like to take a drug from the laboratory to market

en

35:25

Why everything starts with great culture

Molecule to Market: Inside the outsourcing space ·

2022/09/08

In this special repurposed episode of Molecule to Market, we go back inside the global drug development space with previous guests Magnus Gustafsson, Board Member at Genovis, Jeff Dill, CEO at Vynamic. , and Peter Soelkner, Managing Director at Vetter to hear their thoughts on building a great organisational culture. Your host, Raman Sehgal, revisits discussions from past episodes, with amazing global guests who share their insights about building culture to give our listeners loads of takeaway

en

57:46

The orphan drug entrepreneur

Molecule to Market: Inside the outsourcing space ·

2022/08/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Evelyn Kelly, Chief Executive Officer at Orphan Drug Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Evelyn, covering: A deep dive into the world of orphan drugs, rare diseases and personalised medicines including the background, evolution and fast growth of the area. The revolution in drug development that we are living

en

48:21

The wonder of Wurster technology

Molecule to Market: Inside the outsourcing space ·

2022/07/22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chuck Frey, VP Scientific Affairs at Coating Place. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chuck, covering: The backstory to Wurster coating technology and how it changed the world of formulation development. Being the go-to guys for the most challenging processing projects... when no one else in the market can. The advantages

en

56:13

Biotech trends you need to know

Molecule to Market: Inside the outsourcing space ·

2022/07/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Allan Shaw, Consulting CFO, Special Advisor & Board Member of several biotech companies. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Allan, covering: The sensitive cash position of biotech's as a ‘hangover’ after a decade of partying as the market was high. The potential domino effect and collateral impact of the biotech capital

en

18:13

Biotech briefs

Molecule to Market: Inside the outsourcing space ·

2022/07/08

In this special episode of Molecule to Market, we go back inside the global drug development space with previous guests Go van Dam, CEO & Founder at TRACER, Michelle Duggan, Inward Investment Manager, Invest North East England, Peter Soelkner, Managing Director at Vetter and Ross Burn, Chief Executive at CatSci. Your host, Raman Sehgal, revisits discussions around trends in the biotech space, from episodes including: Physician. Scientist. Entrepreneur. The UK’s hidden life science gem From

en

43:11

Africa’s biotech butterfly

Molecule to Market: Inside the outsourcing space ·

2022/06/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adrienne Leussa, Director of Ecosystem Partnerships at 54gene.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adrienne, covering: How the reality of the health challenges living in Africa as a child drove Adrienne into the drug discovery space. A rich insight into the only remaining high growth market globally for pharma companies. Learn

en

51:48

The global pharma leader with an eye on societal impact

Molecule to Market: Inside the outsourcing space ·

2022/06/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Enloe, President and CEO at Societal™ CDMO. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering: Being at the birth of viral vectors and the-infant gene therapy field in the 90s... but choosing not to be there today. After a career spent all over the world - he shares his pearls of wisdom of what he’s learnt from a

en

41:55

From PhD to Pioneer

Molecule to Market: Inside the outsourcing space ·

2022/06/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ata Tuna Ciftlik CEO at Lunaphore.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ata, covering: Bringing the next generation ‘satellite for tumours’ sequencing tools for immuno oncology and cancer research to drug discovery, and eventually the mainstream. Why life science start-ups need data to survive and thrive. And key lessons of

en

28:57

Supply chain challenges and trends

Molecule to Market: Inside the outsourcing space ·

2022/06/10

In this special one-off episode of Molecule to Market, your host Raman Sehgal embarks on a solo cast to cover some of the major supply chain themes uncovered through Molecule to Market interviews. The insights were originally delivered live on stage at CPhI North America 2022. Whether you’re a CDMO, CPO, drug sponsor or equipment vendor - this is not to be missed.Your host, Raman, covers: 4 main challenges the sector has felt over the last two years 4 solutions we are seeing and that you may want

en

22:59

Chats from CPhI North America

Molecule to Market: Inside the outsourcing space ·

2022/05/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses the pharmaceutical and biotechnology supply chain live from CPhI North America 2022, with: Robert Lee, President at Lubrizol Life Science Health - CDMO Division at The Lubrizol Corporation Lauren (Naughton) Hanna, Publisher at Contract Pharma Bob Macadangdang, Client Development Manager at Sharp, Contract Pharmaceutical Packaging Stephen

en

43:16

The BioPharmGuy

Molecule to Market: Inside the outsourcing space ·

2022/05/16

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Wilson, President - BioPharmGuy. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: The humble start-up story and journey of the biopharmguy. The pivot that took the website from being a job sharing site to one of the most widely-regarded and used platforms in the biotech world. The value of simply focussing on looking

en

26:26

Chronicles of Swiss Biotech day

Molecule to Market: Inside the outsourcing space ·

2022/05/11

Event season is truly well on its way and where better to start than Swiss Biotech Day, the leading biotechnology conference in Switzerland. Renowned for its innovative biotech start-ups and big pharma companies all in attendance, it was a great chance to meet experts from the life science industry from across Europe. Which is why it should come as no surprise that your host Raman Sehgal brought Molecule to market once more to the event space. If you loved the ‘Memoir of DCAT 2022’ episode, this

en

49:33

From CDMO builder to CDMO creator

Molecule to Market: Inside the outsourcing space ·

2022/05/04

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Terry Novak, President & Chief Executive Officer at Salubrent Pharma Solutions. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Terry, covering: What he has learnt from 40 years in the pharma, biopharma and contract services space The best marketing technique - communicating constantly to your internal audience. The wave of orphan drugs

en

46:08

Built in Boston, now rebuilding businesses

Molecule to Market: Inside the outsourcing space ·

2022/04/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Kallelis, Chief Executive Officer at Mikart. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mike, covering: Growing up, studying and forging a career in Boston during the volatile biotech boom in Massachusetts. His hard-earned 40-years playbook of how to rebuild and revitalise a family owned business by respecting, studying

en

256 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter